Skip to content
  • Home
  • Identity
  • Our Services
  • Countries presence
  • News
  • Contact Us

Day: 1 August 2022

  1. Home
  2. Archives: August 2022

Human mesenchymal stem cell treatment
of premature ovarian failure: new
challenges and opportunities

Human mesenchymal stem cell treatment of premature ovarian failure

Premature ovarian failure (POF) is one of the common disorders found in women leading to 1% female infertility.

Continue reading
adipose tissue stem cells biobank Cord blood Stem cells Swiss stem cells Swiss stem cells biotech

Recent Posts

  • A review: therapeutic potential of adipose- derived stem cells in cutaneous wound healing and regenaration
  • Human mesenchymal stem cell treatment
    of premature ovarian failure: new
    challenges and opportunities
  • Safety and efficacy of intracoronary human umbilical cord-derived mesenchymal stem cell treatment for very old patients with coronary chronic total occlusion
  • Human mesenchymal stem cell treatment
    of premature ovarian failure: new
    challenges and opportunities
  • Autologous Cord Blood Infusions Are Safe and
    Feasible in Young Children with Autism Spectrum
    Disorder: Results of a Single-Center Phase I
    Open-Label Trial

Recent Comments

No comments to show.
Linkedin
  • Home
  • Identity
  • Our Services
  • Countries presence
  • News
  • Contact Us
  • Home
  • Identity
  • Our Services
  • Countries presence
  • News
  • Contact Us

©2022 Swiss Stem Cells Biotech SA – P.IVA CH277426754